Versarien Past Earnings Performance
Past criteria checks 0/6
Versarien's earnings have been declining at an average annual rate of -25.6%, while the Chemicals industry saw earnings declining at 2.5% annually. Revenues have been declining at an average rate of 8.6% per year.
Key information
-25.6%
Earnings growth rate
-16.8%
EPS growth rate
| Chemicals Industry Growth | 4.3% |
| Revenue growth rate | -8.6% |
| Return on equity | -1,312.9% |
| Net Margin | -248.3% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Would Versarien (LON:VRS) Be Better Off With Less Debt?
Aug 05
Would Versarien (LON:VRS) Be Better Off With Less Debt?
Dec 30Shareholders May Be Wary Of Increasing Versarien plc's (LON:VRS) CEO Compensation Package
Sep 16What Kind Of Investors Own Most Of Versarien plc (LON:VRS)?
Feb 24Have Insiders Been Selling Versarien plc (LON:VRS) Shares?
Jan 27
What Does Versarien's (LON:VRS) CEO Pay Reveal?
Dec 15Revenue & Expenses BreakdownBeta
How Versarien makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 5 | -14 | 9 | 0 |
| 31 Mar 23 | 6 | -6 | 7 | 0 |
| 31 Dec 22 | 7 | -6 | 7 | 0 |
| 30 Sep 22 | 7 | -5 | 6 | 0 |
| 31 Mar 22 | 8 | -5 | 6 | 0 |
| 31 Dec 21 | 8 | -6 | 6 | 0 |
| 30 Sep 21 | 8 | -7 | 6 | 0 |
| 30 Jun 21 | 7 | -7 | 6 | 0 |
| 31 Mar 21 | 6 | -8 | 5 | 0 |
| 31 Dec 20 | 6 | -7 | 6 | 0 |
| 30 Sep 20 | 7 | -6 | 6 | 0 |
| 30 Jun 20 | 7 | -5 | 6 | 0 |
| 31 Mar 20 | 8 | -4 | 6 | 0 |
| 31 Dec 19 | 8 | -4 | 6 | 0 |
| 30 Sep 19 | 8 | -4 | 6 | 0 |
| 30 Jun 19 | 9 | -3 | 5 | 0 |
| 31 Mar 19 | 9 | -2 | 5 | 0 |
| 31 Dec 18 | 9 | -2 | 4 | 0 |
| 30 Sep 18 | 10 | -1 | 4 | 0 |
| 30 Jun 18 | 9 | -1 | 4 | 0 |
| 31 Mar 18 | 9 | -1 | 4 | 0 |
| 31 Dec 17 | 9 | -1 | 4 | 0 |
| 30 Sep 17 | 9 | -1 | 4 | 0 |
| 30 Jun 17 | 7 | -2 | 4 | 0 |
| 31 Mar 17 | 6 | -2 | 3 | 0 |
| 31 Dec 16 | 5 | -2 | 3 | 0 |
| 30 Sep 16 | 4 | -2 | 3 | 0 |
| 30 Jun 16 | 4 | -2 | 3 | 0 |
| 31 Mar 16 | 4 | -2 | 3 | 0 |
| 31 Dec 15 | 5 | -2 | 3 | 0 |
| 30 Sep 15 | 5 | -1 | 3 | 0 |
| 30 Jun 15 | 5 | -1 | 3 | 0 |
| 31 Mar 15 | 5 | -1 | 3 | 0 |
| 31 Dec 14 | 5 | -1 | 3 | 0 |
| 30 Sep 14 | 4 | -1 | 2 | 0 |
| 30 Jun 14 | 4 | -1 | 2 | 0 |
| 31 Mar 14 | 3 | -1 | 2 | 0 |
| 31 Dec 13 | 2 | -1 | 1 | 0 |
| 30 Sep 13 | 1 | -1 | 1 | 0 |
| 30 Jun 13 | 1 | -1 | 1 | 0 |
Quality Earnings: VRS is currently unprofitable.
Growing Profit Margin: VRS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VRS is unprofitable, and losses have increased over the past 5 years at a rate of 25.6% per year.
Accelerating Growth: Unable to compare VRS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VRS is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-18.4%).
Return on Equity
High ROE: VRS has a negative Return on Equity (-1312.87%), as it is currently unprofitable.